Free Trial
→ $30 stock to buy before Starlink goes public (WATCH NOW!) (From Paradigm Press) (Ad)tc pixel Free CRBP Stock Alerts

Corbus Pharmaceuticals (CRBP) Earnings Date, Estimates & Call Transcripts

Corbus Pharmaceuticals logo
$7.91 -3.44 (-30.31%)
As of 05/26/2026 04:00 PM Eastern
Compare

Corbus Pharmaceuticals Earnings Summary

Corbus Pharmaceuticals released Q1 2026 earnings on May 12, 2026, reporting an EPS of -$1.23, which beat analysts' consensus estimates of -$1.26 by $0.03. With a trailing EPS of -$5.82, Corbus Pharmaceuticals' earnings are expected to decrease next year, from ($4.83) to ($6.34) per share.

Upcoming Q2
Earnings Date
Aug. 11Before Market OpensEstimated
Consensus EPS
(May. 12)
-$1.26
Actual EPS
(May. 12)
-$1.23 Beat By $0.03

Q1 2026 Earnings Resources

CRBP Upcoming Earnings

Corbus Pharmaceuticals' next earnings date is estimated for Tuesday, August 11, 2026, based on past reporting schedules.

Powered by Quartr
Get Corbus Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Corbus Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

CRBP Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Corbus Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20263-$1.39-$1.15-$1.29
Q2 20264-$1.38-$1.24-$1.30
Q3 20264-$1.52-$1.09-$1.25
Q4 20264-$1.51-$1.15-$1.36

Corbus Pharmaceuticals Earnings History by Quarter

Export
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/11/2026
(Estimated)		--------
5/12/2026Q1 2026-$1.26-$1.23+$0.03-$1.23--
3/9/2026Q4 2025-$1.78-$1.25+$0.53-$1.25$1.11M-
11/12/2025Q3 2025-$1.80-$1.90 -$0.10-$1.90$1.11M-
8/5/2025Q2 2025-$1.55-$1.44+$0.11-$1.44--
5/6/2025Q1 2025-$1.26-$1.39 -$0.13-$1.39--
3/11/2025Q4 2024-$1.02-$0.78+$0.24-$0.78--
11/7/2024--$0.99-$1.15 -$0.16-$1.15--
8/6/2024Q2 2024-$1.19-$0.90+$0.29-$0.90--

Data powered by Fiscal.ai.

Corbus Pharmaceuticals Earnings - Frequently Asked Questions

Corbus Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 11th, 2026 based off last year's report dates. Learn more on CRBP's earnings history.

In the previous quarter, Corbus Pharmaceuticals (NASDAQ:CRBP) reported ($1.23) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.26) by $0.03. Learn more on analysts' earnings estimate vs. CRBP's actual earnings.

Corbus Pharmaceuticals (NASDAQ:CRBP) has a recorded net income of -$78.54 million. CRBP has generated -$5.82 earnings per share over the last four quarters.

Corbus Pharmaceuticals' earnings are expected to decrease from ($4.83) per share to ($6.34) per share in the next year.

Related Companies
Earnings Tools

This page (NASDAQ:CRBP) was last updated on 5/27/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Read now. Do not delete. You’ve been warned.
Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...
Porter & Company | Sponsoredtc pixel
SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...
Weiss Ratings | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel